title: ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology.
authors.forename: V
authors.initials: V
authors.lastname: Fuster
authors.forename: L E
authors.initials: LE
authors.lastname: Rydén
authors.forename: R W
authors.initials: RW
authors.lastname: Asinger
authors.forename: D S
authors.initials: DS
authors.lastname: Cannom
authors.forename: H J
authors.initials: HJ
authors.lastname: Crijns
authors.forename: R L
authors.initials: RL
authors.lastname: Frye
authors.forename: J L
authors.initials: JL
authors.lastname: Halperin
authors.forename: G N
authors.initials: GN
authors.lastname: Kay
authors.forename: W W
authors.initials: WW
authors.lastname: Klein
authors.forename: S
authors.initials: S
authors.lastname: Lévy
authors.forename: R L
authors.initials: RL
authors.lastname: McNamara
authors.forename: E N
authors.initials: EN
authors.lastname: Prystowsky
authors.forename: L S
authors.initials: LS
authors.lastname: Wann
authors.forename: D G
authors.initials: DG
authors.lastname: Wyse
authors.forename: R J
authors.initials: RJ
authors.lastname: Gibbons
authors.forename: E M
authors.initials: EM
authors.lastname: Antman
authors.forename: J S
authors.initials: JS
authors.lastname: Alpert
authors.forename: D P
authors.initials: DP
authors.lastname: Faxon
authors.forename: V
authors.initials: V
authors.lastname: Fuster
authors.forename: G
authors.initials: G
authors.lastname: Gregoratos
authors.forename: L F
authors.initials: LF
authors.lastname: Hiratzka
authors.forename: A K
authors.initials: AK
authors.lastname: Jacobs
authors.forename: R O
authors.initials: RO
authors.lastname: Russell
authors.forename: S C
authors.initials: SC
authors.lastname: Smith
authors.forename: W W
authors.initials: WW
authors.lastname: Klein
authors.forename: A
authors.initials: A
authors.lastname: Alonso-Garcia
authors.forename: C
authors.initials: C
authors.lastname: Blomström-Lundqvist
authors.forename: G
authors.initials: G
authors.lastname: de Backer
authors.forename: M
authors.initials: M
authors.lastname: Flather
authors.forename: J
authors.initials: J
authors.lastname: Hradec
authors.forename: A
authors.initials: A
authors.lastname: Oto
authors.forename: A
authors.initials: A
authors.lastname: Parkhomenko
authors.forename: S
authors.initials: S
authors.lastname: Silber
authors.forename: A
authors.initials: A
authors.lastname: Torbicki
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000465:Algorithms; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D001282:Atrial Flutter / Q000175:diagnosis; D015897:Comorbidity; D003937:Diagnosis, Differential; D019468:Disease Management; D004554:Electric Countershock; D004562:Electrocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011379:Prognosis; D044469:Racial Groups; D018570:Risk Assessment; D013610:Tachycardia / Q000175:diagnosis; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control
chemical_list: D000889:Anti-Arrhythmia Agents; D005343:Fibrinolytic Agents